Toe Amputations in Patients With Diabetes
PANDORAT
1 other identifier
interventional
102
1 country
1
Brief Summary
This study is a randomized controlled trial (RCT) to evaluate outcome after toe amputation due to diabetic foot infection. Aim of this RCT is to evaluate wound healing and functional outcome based, whether wound is closed or left open. As a part of this study, emerging technology of thermal imaging is evaluated as a possible tool to predict complication after amputation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2023
CompletedFirst Posted
Study publicly available on registry
May 12, 2023
CompletedStudy Start
First participant enrolled
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedDecember 12, 2023
December 1, 2023
1.9 years
April 5, 2023
December 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound healed
Percentage of patients with completely healed (no dehiscence, necrosis etc.) wound in 3 month control visit
3 months
Secondary Outcomes (4)
Complications
3 months
Functional outcome: 15D
3 months
Functional outcome: TESS
3 months
Functional outcome: FHSQ
3 months
Study Arms (2)
Closed wound
ACTIVE COMPARATORWound is closer immediately after amputation (instead healing secondarily)
Open wound
NO INTERVENTIONWound is left to heal secondarily
Interventions
Wound is closed or left open to heal secondarily after amputation.
Eligibility Criteria
You may qualify if:
- Toe amputation due to diabetic foot infection
You may not qualify if:
- Deep foot infection
- Sepsis
- No clinical infection (amputation due to trauma, deformity or uninfected necrosis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampere University Hospital
Tampere, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miska Vuorlaakso, PhD
Tampere University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 5, 2023
First Posted
May 12, 2023
Study Start
May 22, 2023
Primary Completion
May 1, 2025
Study Completion
May 1, 2025
Last Updated
December 12, 2023
Record last verified: 2023-12